Investigating potential claims involving Relmada Therapeutics
Relmada Therapeutics is a clinical-stage, publicly traded biotechnology company developing novel medicines that potentially address areas of high unmet medical need in the treatment of central nervous system (CNS) diseases.
The company filed a form D to raise capital in 2012. According to the Form D filing, the company is located in Blue Bell, PA.
Investments such as these are typically sold by brokerage firms in exchange for a large up front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%.
The problem with private placement investments such as Relmada Therapeutics is that they involve a high degree of risk. They are typically sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds. These investments may seem wise at first, until the dramatic drop in distributions.
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly selling high-risk private placements, like Relmada Therapeutics, to investors.
Despite the risks of investing in private placements, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
If a brokerage firm makes unsuitable investment recommendations or fails to adequately disclose the risks associated with an investment they may be liable for investment losses through FINRA arbitration.
FINRA operates the largest securities dispute resolution forum in the United States, and has extensive experience in providing a fair, efficient and effective venue to handle a securities-related dispute.
If you have concerns regarding your investment in Relmada Therapeutics, The White Law Group may be able to help you. To speak with a securities attorney about your options, please call The White Law Group at 888-637-5510 for a free consultation.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://whitesecuritieslaw.com.
Tags: Relmada Therapeutics, Relmada Therapeutics help, Relmada Therapeutics high commissions, Relmada Therapeutics information, Relmada Therapeutics investment, Relmada Therapeutics investor relations, Relmada Therapeutics investors, Relmada Therapeutics ppm, Relmada Therapeutics private placement, Relmada Therapeutics prospectus, Relmada Therapeutics real estate, Relmada Therapeutics risk, Relmada Therapeutics update, Relmada Therapeutics value Last modified: January 10, 2018